Longevity & biohacking
Longevity Science: The Economics of Cellular Senescence
In 2023, U.S. healthcare spending on age-related diseases climbed 3.5% to $4.1 trillion, propelling senescence to the forefront of economic policy. With biotech, insurers, and investors racing to shape the market, the longevity boom is redefining budgets and opportunities. Medical Disclaimer: This article is for informational purposes